Arynta (Lisdexamfetamine) dosage and usage
Arynta (Lisdexamfetamine) is a central nervous system stimulant drug approved for sale in the form of an oral solution. Its main clinical applications include two aspects: first, it is used to treat attention deficit hyperactivity disorder (ADHD) in adults and children aged 6 years and above; second, it is used to treat moderate to severe binge eating disorder (BED) in adults. As the first oral liquid formulation of lisdexamethasone dimesylate, Arynta is especially suitable for patients who have difficulty swallowing capsules or tablets, improving compliance and convenience of use.
In terms of specific usage and dosage, Arynta needs to be taken orally once a day, and it is recommended to be used in the morning to reduce insomnia and other side effects related to central nervous system excitement. For the treatment of ADHD, the recommended starting dose for adults and children 6 years and older is 30 mg daily in the morning, which can be increased by 10 to 20 mg weekly based on the patient's clinical response and tolerance. The recommended maintenance dose range is 30 to 70 mg daily, while the maximum daily dose should not exceed 70 mg. For adults with binge eating disorder, the starting dose is also 30 mg daily in the morning, and the titration method is usually increased by 20 mg weekly. The recommended dose is between 50 and 70 mg daily, and the maximum dose is also limited to 70 mg daily. It should be noted that Arynta should be adjusted under the guidance of a doctor and avoid increasing or decreasing the dosage on your own. If obvious adverse reactions or insufficient efficacy occur, a follow-up visit should be made in time to adjust the treatment plan.
BecauseArynta is a drug with potential for abuse and dependence, so it must be used strictly as prescribed. Patients should avoid taking medication at night to reduce the risk of insomnia; at the same time, they should pay attention to monitoring blood pressure, heart rate, and weight changes, especially in children and adolescents, who need to pay attention to the long-term effects on height and weight development.
Reference materials:https://www.drugs.com/arynta.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)